FIELD: medicine.
SUBSTANCE: invention relates to medicine and deals with method of treating chronic viral hepatitis C, which includes oral introduction into organism of liposomal medication alpha-2 interferon in from of "Reaferon-EU-Lipint" and liposomal medication ribavirin in form of "Ribavirin-LIPINT", as well as introduction into organism of injection form of alpha-2 interferon in form of "Reaferon-EU".
EFFECT: invention ensures reduction of treatment terms by increasing efficiency of antiviral action of complex of medications, applied in accordance with claimed method of treating chronic viral hepatitis C without increasing toxic impact on patient's organism.
2 cl, 1 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS TYPE C | 2006 |
|
RU2345787C2 |
METHOD OF TREATING TICK-BORNE ENCEPHALITIS | 2011 |
|
RU2473364C2 |
METHOD FOR TREATING ACUTE HEPRETIC STOMATITIS IN CHILDREN | 2011 |
|
RU2444372C1 |
METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2010 |
|
RU2424821C1 |
METHOD FOR BODY PROTECTION AGAINST INFECTION CAUSED BY INFLUENZA A VIRUS SUBTYPE H1N1 STRAINS WITH PREPARATION OF HUMAN ALPHA-2 INTERFERON | 2013 |
|
RU2523554C1 |
METHOD FOR PREDICTION OF IF THERAPY EFFECTIVENESS FOR VIRAL HEPATITIS IN CHILDREN | 2008 |
|
RU2379689C1 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C | 2010 |
|
RU2429877C1 |
ANTI-ENTEROVIRAL AND IMMUNOSTIMULATING AGENT | 2014 |
|
RU2554761C1 |
Authors
Dates
2013-02-20—Published
2011-12-22—Filed